Annual report
2689.TEDINET S100RWIR
Period2022-07-01 → 2023-06-30
Filed2023-09-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 148
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥110.5bn | 2022-07-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥108.0bn | 2021-07-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥102.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥97.9bn | 2019-07-01 → 2020-06-30d | Cons. | Net sales (5-year summary) |
| Revenue | ¥98.0bn | 2018-07-01 → 2019-06-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.5bn | 2020-07-01 → 2021-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥906m | 2019-07-01 → 2020-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.3bn | 2018-07-01 → 2019-06-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.2bn | 2022-07-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥2.1bn | 2021-07-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.4bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥989m | 2020-07-01 → 2021-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥326m | 2019-07-01 → 2020-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥776m | 2018-07-01 → 2019-06-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.4bn | 2022-07-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥1.5bn | 2021-07-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥40.9bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥40.0bn | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥36.6bn | at 2021-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.7bn | at 2020-06-30d | Cons. | Total assets (5-year summary) |
| Total assets | ¥33.8bn | at 2019-06-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥30.6bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥30.9bn | at 2022-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥10.3bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥9.1bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥8.1bn | at 2021-06-30d | Cons. | Net assets |
| Net assets / equity | ¥7.3bn | at 2020-06-30d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.8bn | at 2019-06-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.4bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.2bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.4bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.1bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.1bn | at 2021-06-30d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.9bn | at 2020-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1.1bn | at 2019-06-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥660m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.4bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.1bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥863m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥137m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥306m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥212m | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥630m | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥496m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥362m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥176m | 2022-07-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2021-07-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.3bn | 2020-07-01 → 2021-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥440m | 2019-07-01 → 2020-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥63m | 2018-07-01 → 2019-06-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥234.9 | 2022-07-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥252.8 | 2021-07-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥162.66 | 2020-07-01 → 2021-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.76 | 2019-07-01 → 2020-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.24 | 2018-07-01 → 2019-06-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Net assets per share | ¥1,712.19 | at 2023-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,513.91 | at 2022-06-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,336.91 | at 2021-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,197.17 | at 2020-06-30d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥1,191.62 | at 2019-06-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 25.3% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.8% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.2% | at 2021-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.6% | at 2020-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 19.8% | at 2019-06-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 14.6% | 2022-07-01 → 2023-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 17.8% | 2021-07-01 → 2022-06-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.8% | 2020-07-01 → 2021-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.7% | 2019-07-01 → 2020-06-30d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 12.0% | 2018-07-01 → 2019-06-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,317 | at 2023-06-30 | Cons. | Number of employees |
| Employees | 1,289 | at 2022-06-30 | Cons. | Number of employees |
| Employees | 1,261 | at 2021-06-30d | Cons. | Number of employees |
| Employees | 1,222 | at 2020-06-30d | Cons. | Number of employees |
| Employees | 1,189 | at 2019-06-30d | Cons. | Number of employees |
| Revenue | ¥1.9bn | 2022-07-01 → 2023-06-30 | Standalone | Net sales |
| Revenue | ¥2.2bn | 2021-07-01 → 2022-06-30 | Standalone | Net sales |
| Revenue | ¥1.7bn | 2020-07-01 → 2021-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2019-07-01 → 2020-06-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.6bn | 2018-07-01 → 2019-06-30d | Standalone | Net sales (5-year summary) |
| Operating income | ¥630m | 2022-07-01 → 2023-06-30 | Standalone | Operating income |
| Operating income | ¥1.0bn | 2021-07-01 → 2022-06-30 | Standalone | Operating income |
| Ordinary income | ¥631m | 2022-07-01 → 2023-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥1.0bn | 2021-07-01 → 2022-06-30 | Standalone | Ordinary income |
| Ordinary income | ¥477m | 2020-07-01 → 2021-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥239m | 2019-07-01 → 2020-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥447m | 2018-07-01 → 2019-06-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥630m | 2022-07-01 → 2023-06-30 | Standalone | Income before income taxes |
| Profit before tax | ¥993m | 2021-07-01 → 2022-06-30 | Standalone | Income before income taxes |
| Net income | ¥549m | 2022-07-01 → 2023-06-30 | Standalone | Profit loss |
| Net income | ¥999m | 2021-07-01 → 2022-06-30 | Standalone | Profit loss |
| Net income | ¥384m | 2020-07-01 → 2021-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | −¥228m | 2019-07-01 → 2020-06-30d | Standalone | Net income loss (5-year summary) |
| Net income | ¥260m | 2018-07-01 → 2019-06-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥8.1bn | at 2023-06-30 | Standalone | Assets |
| Total assets | ¥8.9bn | at 2022-06-30 | Standalone | Assets |
| Total assets | ¥7.8bn | at 2021-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.8bn | at 2020-06-30d | Standalone | Total assets (5-year summary) |
| Total assets | ¥8.1bn | at 2019-06-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.2bn | at 2023-06-30 | Standalone | Liabilities |
| Total liabilities | ¥4.3bn | at 2022-06-30 | Standalone | Liabilities |
| Net assets / equity | ¥4.9bn | at 2023-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.7bn | at 2022-06-30 | Standalone | Net assets |
| Net assets / equity | ¥4.1bn | at 2021-06-30d | Standalone | Net assets |
| Net assets / equity | ¥4.0bn | at 2020-06-30d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥4.0bn | at 2019-06-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥922m | at 2023-06-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.9bn | at 2022-06-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥91.25 | 2022-07-01 → 2023-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥164.46 | 2021-07-01 → 2022-06-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥63.17 | 2020-07-01 → 2021-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-39.73 | 2019-07-01 → 2020-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.31 | 2018-07-01 → 2019-06-30d | Standalone | Basic earnings loss per share (5-year summary) |
| Dividend per share | ¥70 | 2022-07-01 → 2023-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥60 | 2021-07-01 → 2022-06-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥50 | 2020-07-01 → 2021-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥45 | 2019-07-01 → 2020-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2018-07-01 → 2019-06-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥809.18 | at 2023-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥775.62 | at 2022-06-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥673.94 | at 2021-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥656.64 | at 2020-06-30d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥710.19 | at 2019-06-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 60.1% | at 2023-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.1% | at 2022-06-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 52.3% | at 2021-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 45.5% | at 2020-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 49.5% | at 2019-06-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 11.5% | 2022-07-01 → 2023-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2021-07-01 → 2022-06-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 9.5% | 2020-07-01 → 2021-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | -5.7% | 2019-07-01 → 2020-06-30d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.5% | 2018-07-01 → 2019-06-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 6,250,000 | at 2023-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2022-06-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2021-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2020-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,250,000 | at 2019-06-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 47 | at 2023-06-30 | Standalone | Number of employees |
| Employees | 41 | at 2022-06-30 | Standalone | Number of employees |
| Employees | 39 | at 2021-06-30d | Standalone | Number of employees |
| Employees | 37 | at 2020-06-30d | Standalone | Number of employees |
| Employees | 34 | at 2019-06-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 71
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | capex | 2022-07-01 → 2023-06-30 | ¥59m |
| Reconciling Itemsreconciling | depreciation | 2022-07-01 → 2023-06-30 | ¥35m |
| Reconciling Itemsreconciling | revenue | 2022-07-01 → 2023-06-30 | −¥1.5bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-07-01 → 2023-06-30 | −¥1.5bn |
| Reconciling Itemsreconciling | segment assets | at 2023-06-30 | −¥3.4bn |
| Reconciling Itemsreconciling | segment profit | 2022-07-01 → 2023-06-30 | −¥119m |
| Care Nursing Goodsreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥6m |
| Care Nursing Goodsreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | employees | at 2023-06-30 | 138 pure |
| Care Nursing Goodsreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Care Nursing Goodsreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥2.5bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥634,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2023-06-30 | ¥1.1bn |
| Care Nursing Goodsreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥201m |
| Medical Equipmentreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥270m |
| Medical Equipmentreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥439m |
| Medical Equipmentreportable segment | employees | at 2023-06-30 | 955 pure |
| Medical Equipmentreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥104.2bn |
| Medical Equipmentreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥102.8bn |
| Medical Equipmentreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥1.4bn |
| Medical Equipmentreportable segment | segment assets | at 2023-06-30 | ¥37.5bn |
| Medical Equipmentreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥1.9bn |
| SPDreportable segment | capex | 2022-07-01 → 2023-06-30 | ¥15m |
| SPDreportable segment | depreciation | 2022-07-01 → 2023-06-30 | ¥21m |
| SPDreportable segment | employees | at 2023-06-30 | 177 pure |
| SPDreportable segment | revenue | 2022-07-01 → 2023-06-30 | ¥5.3bn |
| SPDreportable segment | revenue external | 2022-07-01 → 2023-06-30 | ¥5.1bn |
| SPDreportable segment | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥128m |
| SPDreportable segment | segment assets | at 2023-06-30 | ¥5.7bn |
| SPDreportable segment | segment profit | 2022-07-01 → 2023-06-30 | ¥172m |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-07-01 → 2023-06-30 | ¥291m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-07-01 → 2023-06-30 | ¥464m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-07-01 → 2023-06-30 | ¥112.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-07-01 → 2023-06-30 | ¥110.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-07-01 → 2023-06-30 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-06-30 | ¥44.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-07-01 → 2023-06-30 | ¥2.3bn |
| Reconciling Itemsreconciling | capex | 2021-07-01 → 2022-06-30 | ¥91m |
| Reconciling Itemsreconciling | depreciation | 2021-07-01 → 2022-06-30 | ¥32m |
| Reconciling Itemsreconciling | revenue | 2021-07-01 → 2022-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2021-07-01 → 2022-06-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment assets | at 2022-06-30 | −¥4.4bn |
| Reconciling Itemsreconciling | segment profit | 2021-07-01 → 2022-06-30 | −¥158m |
| Care Nursing Goodsreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥1m |
| Care Nursing Goodsreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥4m |
| Care Nursing Goodsreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Care Nursing Goodsreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥2.4bn |
| Care Nursing Goodsreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥559,000 |
| Care Nursing Goodsreportable segment | segment assets | at 2022-06-30 | ¥983m |
| Care Nursing Goodsreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥171m |
| Medical Equipmentreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥374m |
| Medical Equipmentreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥344m |
| Medical Equipmentreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥102.2bn |
| Medical Equipmentreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥101.0bn |
| Medical Equipmentreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥1.2bn |
| Medical Equipmentreportable segment | segment assets | at 2022-06-30 | ¥37.8bn |
| Medical Equipmentreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥1.9bn |
| SPDreportable segment | capex | 2021-07-01 → 2022-06-30 | ¥12m |
| SPDreportable segment | depreciation | 2021-07-01 → 2022-06-30 | ¥19m |
| SPDreportable segment | revenue | 2021-07-01 → 2022-06-30 | ¥4.7bn |
| SPDreportable segment | revenue external | 2021-07-01 → 2022-06-30 | ¥4.6bn |
| SPDreportable segment | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥154m |
| SPDreportable segment | segment assets | at 2022-06-30 | ¥5.5bn |
| SPDreportable segment | segment profit | 2021-07-01 → 2022-06-30 | ¥171m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-07-01 → 2022-06-30 | ¥387m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-07-01 → 2022-06-30 | ¥367m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-07-01 → 2022-06-30 | ¥109.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-07-01 → 2022-06-30 | ¥108.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-07-01 → 2022-06-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-06-30 | ¥44.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-07-01 → 2022-06-30 | ¥2.2bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,495
| Item | Context | Value | Unit |
|---|---|---|---|
| Consolidated balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of changes in equity (text) | CurrentYearDuration | Text · Plus | |
| Consolidated statement of cash flows (text) | CurrentYearDuration | Text · Plus | |
| Notes significant accounting policies for preparation of consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Number of consolidated subsidiaries and names of major consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and reasons for exclusion from scope of consolidation (text) | CurrentYearDuration | Text · Plus | |
| Number of unconsolidated subsidiaries and associates accounted for using equity method and names of major entities accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Names of major unconsolidated subsidiaries and associates and reasons for not being accounted for using equity method (text) | CurrentYearDuration | Text · Plus | |
| Disclosure about fiscal years etc of consolidated subsidiaries (text) | CurrentYearDuration | Text · Plus | |
| Disclosure of accounting policies (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in accounting policies in accordance with changes in accounting standards etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes new accounting standards not yet applied consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes changes in presentation consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes additional information consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding pledged assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of notes and accounts receivable trade and contract assets (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amounts of reduction entry of property plant and equipment (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding shares and bonds etc of unconsolidated subsidiaries and associates (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of contract liabilities (text) | CurrentYearInstant | Text · Plus | |
| Notes regarding amount of revenue from contracts with customers (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding write downs of inventories (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding gain on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on sales of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding loss on disposal of property plant and equipment (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding impairment loss (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding reclassification adjustments and tax effects relating to other comprehensive income (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding dividend (text) | Prior1YearDuration | Text · Plus | |
| Notes regarding issued shares and treasury shares (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding new share subscription rights etc (text) | CurrentYearDuration | Text · Plus | |
| Notes regarding dividend (text) | CurrentYearDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | CurrentYearDuration | Text · Plus | |
| Major components of assets and liabilities of consolidated subsidiary acquired by purchase of shares during reporting period (text) | CurrentYearDuration | Text · Plus | |
| Description of significant transactions not requiring use of cash or cash equivalents (text) | CurrentYearDuration | Text · Plus | |
| Notes leases consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes financial instruments consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes securities consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes retirement benefits consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes tax effect accounting consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes asset retirement obligations consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes real estate for lease etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes revenue recognition consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Notes segment information etc consolidated financial statements (text) | CurrentYearDuration | Text · Plus | |
| Description of reportable segments (text) | CurrentYearDuration | Text · Plus | |
| Explanation of measurements of sales profit loss asset liability and other items for each reportable segment (text) | CurrentYearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | Prior1YearDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | CurrentYearDuration | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |